Floatz logo

CLOMIPHENE CITRATE

Pathologic Processes

Umm Al-Qura UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Pathologic Processes cohort.

Asset / SponsorPhaseRating
Guanfacine
Maimonides Medical Center
Phase 4BB
5-PYRIMIDINECARBOXAMIDE, 2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)-
Celgene
Phase 2CCC
Mrx-2843
Meryx, Inc.
Phase 1CC
METAMIZOLE
Brigham and Women's Hospital
N/AD
VITAMIN D
Umm Al-Qura University
N/AD

View all 9 →

Same molecule, other indications

CLOMIPHENE CITRATE is also rated in:

infertility disorderDormant
A
Indicative ·
81 / 100
View asset →
anovulationDormant
BBB
Indicative ·
79 / 100
View asset →
polycystic ovary syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →